Across TCGA pan-cancer cohorts, TXNDC12 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated TXNDC12 data layer compared with 6 for mass-spec protein.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher TXNDC12 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated TXNDC12 expression acts as an unfavorable survival marker, although some lineages such as COAD and PRAD show a favorable association.
KIRP, HNSC, and LIHC are the cancer types where TXNDC12 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.